Acute electrophysiologic effects of inhaled salbutamol in humans

被引:49
作者
Kallergis, EM
Manios, EG
Kanoupakis, EM
Schiza, SE
Mavrakis, HE
Klapsinos, NK
Vardas, PE [1 ]
机构
[1] Heraklion Univ Hosp, Dept Cardiol, Iraklion 71000, Crete, Greece
[2] Heraklion Univ Hosp, Dept Pneumol, Iraklion 71000, Crete, Greece
关键词
beta(2)-agonist; electrophysiologic effects; refractory period; salbutamol;
D O I
10.1378/chest.127.6.2057
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: Although inhaled beta(2)-agonists are in widespread use, several reports question their potential arrhythmogenic effects. The purpose of this study was to evaluate the cardiac electrophysiologic effects of a single, regular dose of an inhaled beta(2)-agonist in humans. Design: Prospective study. Setting: Tertiary referral center. Patients: Six patients with bronchial asthma and 12 patients with mild COPD. Interventions: All patients underwent an electrophysiologic study before and after the administration of salbutamol solution (5 mg in a single dose). Measurements and results: Sinus cycle length, sinus node recovery time (SNRT), interval from the earliest reproducible rapid deflection of the atrial electrogram in the His bundle recording to the onset of the His deflection (AH), interval from the His deflection to the onset of ventricular depolarization (HV), Wenckebach cycle length (WCL), atrial effective refractory period (AERP), and ventricular effective refractory period (VERP) were evaluated just before and 30 min after the scheduled intervention. Salbutamol, a selective beta(2)-agonist, administered by nebulizer had significant electrophysiologic effects on the atrium, nodes, and ventricle. The AH length decreased from 86.1 +/- 19.5 ms at baseline to 78.8 +/- 18.4 ms (p < 0.001), and the WCL decreased from 354.4 +/- 44.2 to 336.6 +/- 41.7 ms (p = 0.001). Salbutamol significantly decreased the AERP and VERP too while leaving the HV unchanged. Additionally, inhaled salbutamol increased heart rate (from 75.5 +/- 12.8 beats/min at baseline to 93.1 +/- 16 beats/min, p < 0.001) and shortened the SNRT (from 1,073.5 +/- 178.7 to 925.2 +/- 204.9 ms, p = 0.001). Conclusion: Inhaled salbutamol results in significant changes of cardiac electrophysiologic properties. Salbutamol enhances atrioventricular (AV) nodal conduction and decreases AV nodal, atrial, and ventricular refractoriness in addition to its positive chronotropic effects. These alterations could contribute to the generation of spontaneous arrhythmias.
引用
收藏
页码:2057 / 2063
页数:7
相关论文
共 33 条
[11]   CARDIOVASCULAR AND HYPOKALEMIC EFFECTS OF INHALED SALBUTAMOL, FENOTEROL, AND ISOPRENALINE [J].
CRANE, J ;
BURGESS, C ;
BEASLEY, R .
THORAX, 1989, 44 (02) :136-140
[12]   Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: Progressive reduction of beta(1)-adrenergic receptor mRNA in heart failure [J].
Engelhardt, S ;
Bohm, M ;
Erdmann, E ;
Lohse, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (01) :146-154
[13]   THE CARDIOVASCULAR EFFECTS OF BETA-ADRENERGIC AGONIST DRUGS ADMINISTERED BY NEBULIZATION [J].
FLATT, A ;
CRANE, J ;
PURDIE, G ;
KWONG, T ;
BEASLEY, R ;
BURGESS, C .
POSTGRADUATE MEDICAL JOURNAL, 1990, 66 (772) :98-101
[14]   ASSESSMENT OF THE BETA-ADRENERGIC-RECEPTOR PATHWAY IN THE INTACT FAILING HUMAN-HEART - PROGRESSIVE RECEPTOR DOWN-REGULATION AND SUBSENSITIVITY TO AGONIST RESPONSE [J].
FOWLER, MB ;
LASER, JA ;
HOPKINS, GL ;
MINOBE, W ;
BRISTOW, MR .
CIRCULATION, 1986, 74 (06) :1290-1302
[15]   Functional role of β2-adrenoceptors in the transplanted human heart [J].
Hakim, K ;
Fischer, M ;
Günnicker, M ;
Poenicke, K ;
Zerkowski, HR ;
Brodde, OE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 30 (06) :811-816
[16]   INTRACORONARY INJECTIONS OF SALBUTAMOL DEMONSTRATE THE PRESENCE OF FUNCTIONAL BETA-2-ADRENOCEPTORS IN THE HUMAN-HEART [J].
HALL, JA ;
PETCH, MC ;
BROWN, MJ .
CIRCULATION RESEARCH, 1989, 65 (03) :546-553
[17]   ADRENERGIC EFFECTS ON VENTRICULAR VULNERABILITY [J].
HAN, J ;
DEJALON, PG ;
MOE, GK .
CIRCULATION RESEARCH, 1964, 14 (06) :516-&
[18]   Electrophysiologic effects of salbutamol, a β2-selective agonist [J].
Insulander, P ;
Juhlin-Dannfelt, A ;
Freyschuss, U ;
Vallin, H .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (03) :316-322
[19]  
JANSON C, 1991, EUR RESPIR J, V4, P544
[20]  
Josephson M.E., 1993, CLIN CARDIAC ELECTRO, P22